Anterix IncATEX
± MixedCapitalrelevance
Shareholder approval of routine governance items, including stock plan expansion, has no clear directional impact on Anterix's business.

Anterix shareholders approved all five proposals at the 2026 annual meeting, including the reelection of seven directors through the 2027 annual meeting. Investors approved the company's executive compensation on an advisory basis, selected annual say-on-pay votes, and amended the 2023 Stock Plan to increase shares available for employees and non-employee directors. Shareholders also ratified Deloitte & Touche as Anterix's independent auditor for the fiscal year ending March 31, 2027; final voting results will be filed in a Form 8-K.
Anterix IncShareholder approval of routine governance items, including stock plan expansion, has no clear directional impact on Anterix's business.